What does Jinlong Pharmaceutical do?
Jinlong Pharmaceutical Co., Ltd., Kunming Jinlong Pharmaceutical Co., Ltd., was established in1September 1996 with a registered capital of 400.5 million yuan. "Golden Dragon moistens the stone, Kang Ze hides the sage"-the initial intention of Jinlong Pharmaceutical, whose mission is to protect life, improve human health and enjoy a comfortable life. Always uphold the values of ingenuity, success, innovation, honesty and pragmatism. Jinlong Pharmaceutical is committed to becoming an industry leader with innovative spirit, respected by the world and trusted by its partners for a long time.
Jinlong Pharmaceutical focuses on the development, research, production and sales of therapeutic drugs for cardiovascular and cerebrovascular diseases and metabolic diseases. Jinlong Pharmaceutical won the special project of pre-clinical research on major new drug creation in the 13th Five-Year Plan (20 18), the special project of standardization of traditional Chinese medicine jointly implemented by the National Development and Reform Commission and state administration of traditional chinese medicine (20 16), the special project of technological transformation of major new drug creation in the 12th Five-Year Plan of the Ministry of Science and Technology (20 12, 2065438+) and many other national-level projects. The leading products of the company are breviscapine lyophilized powder for injection.
Over the years, our company has devoted itself to the in-depth study of the formula and preparation technology of breviscapine for injection, and mastered the relevant core technologies. The quality standard of breviscapine for injection drafted by the company has been included in China Pharmacopoeia, and it is the only monomer preparation with a purity of 98%. The company obtained 17 national invention patents from raw materials to preparations.
At present, the company has nearly 30 invention patents at home and abroad. In 20 16, the company's smart factory construction project was officially launched. Through the three integrations of "full supply chain integration, full information integration and full automation integration", Jinlong Pharmaceutical has become a benchmark enterprise of intelligent manufacturing in the pharmaceutical industry with "high quality, high efficiency and low energy consumption".